Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors — Stella

Home/Solid Cancer/TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Solid Cancer trials

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

China

Beijing Gobroad Hospital, Beijing, Beijing Municipality

GoBroad Healthcare Group, Beijing, Beijing Municipality

Key details

Phase

Very early testing

Sponsor

Beijing GoBroad Hospital

Enrollment target

~30 participants

Started

December 2025

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.